These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1965782)

  • 1. Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties.
    Goodchild J
    Bioconjug Chem; 1990; 1(3):165-87. PubMed ID: 1965782
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-hydroxybenzylphosphonate modified oligonucleotides: synthesis, properties, and a novel route via monomer building blocks.
    Hohlfeld A; Meier C
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1123-5. PubMed ID: 14565360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, base-pairing properties and enzymatic stability.
    Augustyns K; Vandendriessche F; Van Aerschot A; Busson R; Urbanke C; Herdewijn P
    Nucleic Acids Res; 1992 Sep; 20(18):4711-6. PubMed ID: 1329028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA.
    Winkler J; Gilbert M; Kocourková A; Stessl M; Noe CR
    ChemMedChem; 2008 Jan; 3(1):102-10. PubMed ID: 17979170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backbone modifications in oligonucleotides and peptide nucleic acid systems.
    De Mesmaeker A; Altmann KH; Waldner A; Wendeborn S
    Curr Opin Struct Biol; 1995 Jun; 5(3):343-55. PubMed ID: 7583633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters.
    Ravikumar VT; Kumar RK; Capaldi DC; Cole DL
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative inhibition of ras p21 protein synthesis with phosphorus-modified antisense oligonucleotides.
    Chang EH; Yu Z; Shinozuka K; Zon G; Wilson WD; Strekowska A
    Anticancer Drug Des; 1989 Oct; 4(3):221-32. PubMed ID: 2679622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and properties of modified oligonucleotides.
    Letsinger RL; Alul RA; Farooqui F; Gryaznov SM; Kinstler O
    Nucleic Acids Symp Ser; 1991; (24):75-8. PubMed ID: 1841386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2'-modified oligonucleotides containing aldehyde or ethylenediamine groups.
    Zatsepin TS; Romanova EA; Stetsenko DA; Gait MJ; Oretskaya TS
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1383-5. PubMed ID: 14565424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays.
    Southern EM; Milner N; Mir KU
    Ciba Found Symp; 1997; 209():38-44; discussion 44-6. PubMed ID: 9383567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retro-1-Oligonucleotide Conjugates. Synthesis and Biological Evaluation.
    Agramunt J; Pedroso E; Kreda SM; Juliano RL; Grandas A
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30736307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory properties of double-helix-forming circular oligonucleotides.
    Azhayeva E; Azhayev A; Auriola S; Tengvall U; Urtti A; Lönnberg
    Nucleic Acids Res; 1997 Dec; 25(24):4954-61. PubMed ID: 9396802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acids--genes, drugs, molecular lego and more.
    Häner R
    Chimia (Aarau); 2010; 64(1-2):14-6. PubMed ID: 21137677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of therapeutic locked nucleos(t)ides.
    Zhou C; Chattopadhyaya J
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):876-98. PubMed ID: 19894196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short, novel, and cheaper procedure for oligonucleotide synthesis using automated solid phase synthesizer.
    Song Q; Wang Z; Sanghvi YS
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):629-33. PubMed ID: 14565241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reactions of H-phosphonates with bifunctional reagents. Part V. Functionalization of support-bound oligonucleotides and synthesis of non-radioactive hybridization probes.
    Sobkowski M; Kraszewski A; Stawiński J
    Nucleosides Nucleotides; 1998; 17(1-3):253-67. PubMed ID: 9708350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.